Search - tctmd.com

Displaying 21 - 34 of 34

Sort: Relevancy | Date

News Daily News

Study Finds Exponential Growth in Percutaneous LVAD Use

April 08, 2015

News Daily News

死亡率、住院费用随短期机械辅助循环的使用的增加而降低

November 02, 2014

News Daily News

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

November 02, 2014

News Daily News

La Mortalidad y los Gastos Hospitalarios Caen a medida que Aumenta el Uso del Soporte Circulatorio Mecánico a Corto Plazo

November 02, 2014

News Daily News

IABP疗法可能会让具有大面积STEMI和PCI后持续缺血的患者受益

Caitlin E. Cox

October 03, 2014

News Daily News

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Caitlin E. Cox

October 03, 2014

News Daily News

El Tratamiento con IAMP Podría Beneficiar a Pacientes con STEMI Grandes e Isquemia Persistente Post-PCI

Caitlin E. Cox

October 03, 2014

Presentation TCT 2013

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary...

Presenter: William O'Neill

October 31, 2013

News Daily News

BCIS-1 Published: Elective IABP Benefits High-Risk PCI Patients

Caitlin E. Cox

December 12, 2012

News Daily News

BCIS-1 Publicado: La BBIA Voluntaria Benefica a Pacientes de Alto Riesgo sometidos a PCI

Caitlin E. Cox

December 12, 2012

Presentation TCT 2012

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Presenter: George Dangas

October 23, 2012

News Daily News

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

March 22, 2012

Presentation TCT 2012

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

Presenter: Brijeshwar Maini, William O?Neill, Simon Dixon, Igor Palacios, Theodore Schreiber, David A. Gregory, D. J. Scotti

January 03, 2012

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

Advertisement

Study Finds Exponential Growth in Percutaneous LVAD Use

死亡率、住院费用随短期机械辅助循环的使用的增加而降低

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

La Mortalidad y los Gastos Hospitalarios Caen a medida que Aumenta el Uso del Soporte Circulatorio Mecánico a Corto Plazo

IABP疗法可能会让具有大面积STEMI和PCI后持续缺血的患者受益

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

El Tratamiento con IAMP Podría Beneficiar a Pacientes con STEMI Grandes e Isquemia Persistente Post-PCI

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary...

BCIS-1 Published: Elective IABP Benefits High-Risk PCI Patients

BCIS-1 Publicado: La BBIA Voluntaria Benefica a Pacientes de Alto Riesgo sometidos a PCI

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content